James Mulshine to Biomarkers
This is a "connection" page, showing publications James Mulshine has written about Biomarkers.
Connection Strength
0.254
-
Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules. J Am Coll Radiol. 2015 Apr; 12(4):390-5.
Score: 0.099
-
QIBA guidance: Computed tomography imaging for COVID-19 quantitative imaging applications. Clin Imaging. 2021 Sep; 77:151-157.
Score: 0.037
-
New molecular strategies for early lung cancer detection. Cancer Invest. 2000; 18(6):555-63.
Score: 0.034
-
Biochemical characterization of peptide alpha-amidation enzyme activities of human neuroendocrine lung cancer cell lines. Cell Growth Differ. 1993 Nov; 4(11):911-20.
Score: 0.022
-
Diagnostic research: breakout group report. Cancer Res. 1992 May 01; 52(9 Suppl):2766s.
Score: 0.020
-
Candidate biomarkers for application as intermediate end points of lung carcinogenesis. J Cell Biochem Suppl. 1992; 16G:183-6.
Score: 0.020
-
Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FunLc6Cer). Arch Biochem Biophys. 1989 Nov 15; 275(1):309-14.
Score: 0.017
-
Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am J Clin Pathol. 1992 Feb; 97(2):233-43.
Score: 0.005